Sleep disorders have a profound and well-documented impact on overall health and quality of life in the general population. In patients with chronic disease, sleep disorders are more prevalent, with an additional morb...Sleep disorders have a profound and well-documented impact on overall health and quality of life in the general population. In patients with chronic disease, sleep disorders are more prevalent, with an additional morbidity and mortality burden. The complex and dynamic relationship between sleep disorders and chronic kidney disease(CKD) remain relatively little investigated. This article presents an overview of sleep disorders in patients with CKD, with emphasis on relevant pathophysiologic underpinnings and clinical presentations. Evidence-based interventions will be discussed, in the context of individual sleep disorders, namely sleep apnea, insomnia, restless leg syndrome and excessive daytime sleepiness. Limitations of the current knowledge as well as future research directions will be highlighted, with a final discussion of different conceptual frameworks of the relationship between sleep disorders and CKD.展开更多
Sleep and well-being have been intricately linked,and sleep hygiene is paramount for developing mental well-being and resilience.Although widespread,sleep disorders require elaborate polysomnography laboratory and pat...Sleep and well-being have been intricately linked,and sleep hygiene is paramount for developing mental well-being and resilience.Although widespread,sleep disorders require elaborate polysomnography laboratory and patient-stay with sleep in unfamiliar environments.Current technologies have allowed various devices to diagnose sleep disorders at home.However,these devices are in various validation stages,with many already receiving approvals from competent authorities.This has captured vast patient-related physiologic data for advanced analytics using artificial intelligence through machine and deep learning applications.This is expected to be integrated with patients’Electronic Health Records and provide individualized prescriptive therapy for sleep disorders in the future.展开更多
目的:为克服观察性研究中的混杂因素和反向因果关系的影响,通过两样本孟德尔随机化法探讨失眠与2型糖尿病之间的关联关系。方法:在欧洲裔人群最新的全基因组关联研究(genome-wide association study,GWAS)中选择与失眠密切相关的遗传位...目的:为克服观察性研究中的混杂因素和反向因果关系的影响,通过两样本孟德尔随机化法探讨失眠与2型糖尿病之间的关联关系。方法:在欧洲裔人群最新的全基因组关联研究(genome-wide association study,GWAS)中选择与失眠密切相关的遗传位点作为工具变量。剔除与吸烟、体育活动、饮酒、教育程度、肥胖或2型糖尿病显著相关的位点后,使用逆方差加权评估失眠对2型糖尿病的效应,并采用加权中位数法和MR-Egger回归分析来检验结果的稳健性。通过计算F统计量来检验工具变量的适用性,F统计量大于10认为存在弱工具变量偏倚可能性较小。采用MR-Egger回归进行多效性检验。此外,采用留一法(leave-one-out)进行敏感性分析,以进一步验证结果的稳定性和可靠性。结果:在全基因组水平上选择了248个与失眠独立相关的单核苷酸多态性(single nucleotide polymorphisms,SNPs)作为候选工具变量集合,基于千人基因组计划对候选工具变量集合进行修剪并剔除潜在的多效SNPs后,共纳入与失眠相关的167个SNPs作为最终的工具变量。本研究中F统计量为39.74,符合孟德尔随机化的相关性假设。逆方差加权法发现失眠与2型糖尿病的发生风险较高,在失眠的人群中发生2型糖尿病的风险是无失眠人群的1.14倍(95%CI:1.09~1.21,P<0.001)。加权中位数法和MR-Egger回归结果支持失眠对2型糖尿病存在正向关联。多效性检验表明结果受多效性影响的可能性较小,敏感性分析支持研究结果的可靠性与稳定性。结论:失眠是2型糖尿病的危险因素,失眠与2型糖尿病发病存在正向关联,本研究为糖尿病高危人群保持健康的生活方式提供了进一步的理论依据。展开更多
背景失眠障碍是一种常见的精神疾病,给患者的生活和健康带来严重的负面影响。传统的认知行为疗法(CBT-I)是一种有效的非药物治疗方法,但其操作复杂、耗时长、依从性低等缺点限制了其在真实世界的应用。简版行为疗法(BBT-I)是一种基于CB...背景失眠障碍是一种常见的精神疾病,给患者的生活和健康带来严重的负面影响。传统的认知行为疗法(CBT-I)是一种有效的非药物治疗方法,但其操作复杂、耗时长、依从性低等缺点限制了其在真实世界的应用。简版行为疗法(BBT-I)是一种基于CBT-I的简化治疗方法,其疗效与CBT-I相当,更适合在真实世界中推广。然而,BBT-I是否适用于中国失眠障碍人群暂不明确,而通过线上方式进行BBT-I的研究更是缺乏。目的本研究旨在探讨通过微信小程序进行的在线BBT-I(eBBT-I)对中国失眠障碍患者失眠改善的疗效,以及其对患者睡眠信念和态度的影响。方法本研究采用前瞻性非随机对照研究的设计,将2023年2—11月来自暨南大学附属第一医院精神医学科睡眠门诊的失眠障碍患者设为干预组,将线上和线下招募的失眠障碍志愿者设为对照组,干预组接受为期2周的eBBT-I治疗,对照组接受精神卫生教育的伪干预。在干预前后分别测量患者的失眠严重程度指数量表(ISI)和简版睡眠信念与态度问卷(DBAS-16)得分,以评估干预效果。结果研究最终共纳入35例干预组患者和30例对照组患者。主要结局指标:组别与时间对ISI得分存在交互作用(P<0.05);组别与时间分别对ISI得分主效应显著(P<0.05)。干预前3d(基线)两组ISI得分比较,差异无统计学意义(P>0.05);干预后14d干预组ISI得分低于对照组(P<0.05);干预组干预后14 d ISI得分低于组内干预前(P<0.05)。次要结局指标:组别与时间对DBAS-16得分不存在交互作用(P>0.05);时间对DBAS-16得分主效应显著(P<0.05);组别对DBAS-16得分主效应不显著(P>0.05)。干预前3 d(基线)、干预后14 d两组DBAS-16得分比较,差异无统计学意义(P>0.05);干预组干预后14 d DBAS-16得分高于组内干预前(P<0.05)。结论eBBT-I有效地改善了失眠障碍患者的失眠症状和负面影响,但对睡眠信念与态度的改善效果仍有待提升。本研究支持了eBBT-I在中国失眠障碍患者失眠治疗中的可行性和有效性。展开更多
Objective: This study aimed to examine the sleep quality and prevalence of depression in post myocardial infarction patients attending cardiology outpatient clinics of selected hospitals in Oman.Methods: A descriptive...Objective: This study aimed to examine the sleep quality and prevalence of depression in post myocardial infarction patients attending cardiology outpatient clinics of selected hospitals in Oman.Methods: A descriptive cross-sectional design was used to collect data from patients (n 180) who were at least 4 weeks post myocardial infarction diagnosis and receiving follow-up care in the outpatient clinic.The Arabic version of the Pittsburgh Sleep Quality Index and Patient Health Questionnaire-9 were used to assess sleep quality and depressive symptoms,respectively.Results: The sample mean age was 62.0 ± 11.3 years.Poor sleep quality affected 61.1% of the participants.The significant predictors of poor sleep quality were gender (P ≤ 0.05),body mass index (P ≤ 0.05),and self-reported regular exercise (P ≤ 0.01).The most impacted domains of sleep quality were sleep latency,sleep duration,and sleep disturbances.The prevalence of major depression was low (5%) and the rate of re-infarction was 27.2%.The prevalence of minimal to mild major depression with a potential of transitioning into major depression overtime was very high.Self-reported regular exercise (P ≤ 0.01) was the only significant predictor of depressive symptoms.Conclusion: The sleep quality of post myocardial infarction patients was poor and the prevalence of depression was low.There was no significant relationship between sleep quality or depression with reinfarction.展开更多
目的观察针刺联合耳穴贴压治疗骨髓瘤伴失眠的临床疗效及对认知功能、睡眠质量的影响。方法将160例骨髓瘤中重度疼痛合并失眠患者随机分为观察组(89例)与对照组(71例)。对照组采用常规药物治疗,观察组在对照组基础上采用针刺联合耳穴贴...目的观察针刺联合耳穴贴压治疗骨髓瘤伴失眠的临床疗效及对认知功能、睡眠质量的影响。方法将160例骨髓瘤中重度疼痛合并失眠患者随机分为观察组(89例)与对照组(71例)。对照组采用常规药物治疗,观察组在对照组基础上采用针刺联合耳穴贴压治疗。观察两组治疗前后匹兹堡睡眠质量指数(Pittsburgh sleep quality index,PSQI)评分、简易智力状态检查量表(mini-mental state examination,MMSE)、日常生活活动能力(activity of daily living,ADL)量表、视觉模拟量表(visual analog scale,VAS)、汉密尔顿抑郁量表(Hamilton depression scale,HAMD)及汉密尔顿焦虑量表(Hamilton anxiety scale,HAMA)评分变化,并比较两组临床疗效及骨髓瘤患者认知功能与睡眠质量的关系。结果观察组总有效率为94.4%,显著高于对照组的80.3%,差异有统计学意义(P<0.05)。治疗后,两组PSQI和VAS评分均下降,且观察组低于对照组,差异均有统计学意义(P<0.05);两组MMSE和ADL评分均上升,且观察组高于对照组,差异均有统计学意义(P<0.05)。治疗后,两组HAMD和HAMA评分均下降,且观察组低于对照组,差异有统计学意义(P<0.05)。骨髓瘤患者认知功能与睡眠质量呈现显著正相关(P<0.05)。结论在常规药物基础上,针刺联合耳穴贴压治疗骨髓瘤伴失眠效果显著,能够有效提升患者睡眠质量及认知水平,改善疼痛及负性情绪。展开更多
基金Supported by a NIH grant to Dr.Cukor(MD006875)(in part)
文摘Sleep disorders have a profound and well-documented impact on overall health and quality of life in the general population. In patients with chronic disease, sleep disorders are more prevalent, with an additional morbidity and mortality burden. The complex and dynamic relationship between sleep disorders and chronic kidney disease(CKD) remain relatively little investigated. This article presents an overview of sleep disorders in patients with CKD, with emphasis on relevant pathophysiologic underpinnings and clinical presentations. Evidence-based interventions will be discussed, in the context of individual sleep disorders, namely sleep apnea, insomnia, restless leg syndrome and excessive daytime sleepiness. Limitations of the current knowledge as well as future research directions will be highlighted, with a final discussion of different conceptual frameworks of the relationship between sleep disorders and CKD.
文摘Sleep and well-being have been intricately linked,and sleep hygiene is paramount for developing mental well-being and resilience.Although widespread,sleep disorders require elaborate polysomnography laboratory and patient-stay with sleep in unfamiliar environments.Current technologies have allowed various devices to diagnose sleep disorders at home.However,these devices are in various validation stages,with many already receiving approvals from competent authorities.This has captured vast patient-related physiologic data for advanced analytics using artificial intelligence through machine and deep learning applications.This is expected to be integrated with patients’Electronic Health Records and provide individualized prescriptive therapy for sleep disorders in the future.
文摘目的:为克服观察性研究中的混杂因素和反向因果关系的影响,通过两样本孟德尔随机化法探讨失眠与2型糖尿病之间的关联关系。方法:在欧洲裔人群最新的全基因组关联研究(genome-wide association study,GWAS)中选择与失眠密切相关的遗传位点作为工具变量。剔除与吸烟、体育活动、饮酒、教育程度、肥胖或2型糖尿病显著相关的位点后,使用逆方差加权评估失眠对2型糖尿病的效应,并采用加权中位数法和MR-Egger回归分析来检验结果的稳健性。通过计算F统计量来检验工具变量的适用性,F统计量大于10认为存在弱工具变量偏倚可能性较小。采用MR-Egger回归进行多效性检验。此外,采用留一法(leave-one-out)进行敏感性分析,以进一步验证结果的稳定性和可靠性。结果:在全基因组水平上选择了248个与失眠独立相关的单核苷酸多态性(single nucleotide polymorphisms,SNPs)作为候选工具变量集合,基于千人基因组计划对候选工具变量集合进行修剪并剔除潜在的多效SNPs后,共纳入与失眠相关的167个SNPs作为最终的工具变量。本研究中F统计量为39.74,符合孟德尔随机化的相关性假设。逆方差加权法发现失眠与2型糖尿病的发生风险较高,在失眠的人群中发生2型糖尿病的风险是无失眠人群的1.14倍(95%CI:1.09~1.21,P<0.001)。加权中位数法和MR-Egger回归结果支持失眠对2型糖尿病存在正向关联。多效性检验表明结果受多效性影响的可能性较小,敏感性分析支持研究结果的可靠性与稳定性。结论:失眠是2型糖尿病的危险因素,失眠与2型糖尿病发病存在正向关联,本研究为糖尿病高危人群保持健康的生活方式提供了进一步的理论依据。
文摘背景失眠障碍是一种常见的精神疾病,给患者的生活和健康带来严重的负面影响。传统的认知行为疗法(CBT-I)是一种有效的非药物治疗方法,但其操作复杂、耗时长、依从性低等缺点限制了其在真实世界的应用。简版行为疗法(BBT-I)是一种基于CBT-I的简化治疗方法,其疗效与CBT-I相当,更适合在真实世界中推广。然而,BBT-I是否适用于中国失眠障碍人群暂不明确,而通过线上方式进行BBT-I的研究更是缺乏。目的本研究旨在探讨通过微信小程序进行的在线BBT-I(eBBT-I)对中国失眠障碍患者失眠改善的疗效,以及其对患者睡眠信念和态度的影响。方法本研究采用前瞻性非随机对照研究的设计,将2023年2—11月来自暨南大学附属第一医院精神医学科睡眠门诊的失眠障碍患者设为干预组,将线上和线下招募的失眠障碍志愿者设为对照组,干预组接受为期2周的eBBT-I治疗,对照组接受精神卫生教育的伪干预。在干预前后分别测量患者的失眠严重程度指数量表(ISI)和简版睡眠信念与态度问卷(DBAS-16)得分,以评估干预效果。结果研究最终共纳入35例干预组患者和30例对照组患者。主要结局指标:组别与时间对ISI得分存在交互作用(P<0.05);组别与时间分别对ISI得分主效应显著(P<0.05)。干预前3d(基线)两组ISI得分比较,差异无统计学意义(P>0.05);干预后14d干预组ISI得分低于对照组(P<0.05);干预组干预后14 d ISI得分低于组内干预前(P<0.05)。次要结局指标:组别与时间对DBAS-16得分不存在交互作用(P>0.05);时间对DBAS-16得分主效应显著(P<0.05);组别对DBAS-16得分主效应不显著(P>0.05)。干预前3 d(基线)、干预后14 d两组DBAS-16得分比较,差异无统计学意义(P>0.05);干预组干预后14 d DBAS-16得分高于组内干预前(P<0.05)。结论eBBT-I有效地改善了失眠障碍患者的失眠症状和负面影响,但对睡眠信念与态度的改善效果仍有待提升。本研究支持了eBBT-I在中国失眠障碍患者失眠治疗中的可行性和有效性。
文摘Objective: This study aimed to examine the sleep quality and prevalence of depression in post myocardial infarction patients attending cardiology outpatient clinics of selected hospitals in Oman.Methods: A descriptive cross-sectional design was used to collect data from patients (n 180) who were at least 4 weeks post myocardial infarction diagnosis and receiving follow-up care in the outpatient clinic.The Arabic version of the Pittsburgh Sleep Quality Index and Patient Health Questionnaire-9 were used to assess sleep quality and depressive symptoms,respectively.Results: The sample mean age was 62.0 ± 11.3 years.Poor sleep quality affected 61.1% of the participants.The significant predictors of poor sleep quality were gender (P ≤ 0.05),body mass index (P ≤ 0.05),and self-reported regular exercise (P ≤ 0.01).The most impacted domains of sleep quality were sleep latency,sleep duration,and sleep disturbances.The prevalence of major depression was low (5%) and the rate of re-infarction was 27.2%.The prevalence of minimal to mild major depression with a potential of transitioning into major depression overtime was very high.Self-reported regular exercise (P ≤ 0.01) was the only significant predictor of depressive symptoms.Conclusion: The sleep quality of post myocardial infarction patients was poor and the prevalence of depression was low.There was no significant relationship between sleep quality or depression with reinfarction.
文摘目的观察针刺联合耳穴贴压治疗骨髓瘤伴失眠的临床疗效及对认知功能、睡眠质量的影响。方法将160例骨髓瘤中重度疼痛合并失眠患者随机分为观察组(89例)与对照组(71例)。对照组采用常规药物治疗,观察组在对照组基础上采用针刺联合耳穴贴压治疗。观察两组治疗前后匹兹堡睡眠质量指数(Pittsburgh sleep quality index,PSQI)评分、简易智力状态检查量表(mini-mental state examination,MMSE)、日常生活活动能力(activity of daily living,ADL)量表、视觉模拟量表(visual analog scale,VAS)、汉密尔顿抑郁量表(Hamilton depression scale,HAMD)及汉密尔顿焦虑量表(Hamilton anxiety scale,HAMA)评分变化,并比较两组临床疗效及骨髓瘤患者认知功能与睡眠质量的关系。结果观察组总有效率为94.4%,显著高于对照组的80.3%,差异有统计学意义(P<0.05)。治疗后,两组PSQI和VAS评分均下降,且观察组低于对照组,差异均有统计学意义(P<0.05);两组MMSE和ADL评分均上升,且观察组高于对照组,差异均有统计学意义(P<0.05)。治疗后,两组HAMD和HAMA评分均下降,且观察组低于对照组,差异有统计学意义(P<0.05)。骨髓瘤患者认知功能与睡眠质量呈现显著正相关(P<0.05)。结论在常规药物基础上,针刺联合耳穴贴压治疗骨髓瘤伴失眠效果显著,能够有效提升患者睡眠质量及认知水平,改善疼痛及负性情绪。